Geron Corporation (GON.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:02AM CEST. Market open.
| Previous close | 3.3350 |
| Open | 3.4460 |
| Bid | 3.4100 x 200000 |
| Ask | 3.4970 x 200000 |
| Day's range | 3.4460 - 3.4460 |
| 52-week range | 1.5810 - 3.4850 |
| Volume | |
| Avg. volume | 652 |
| Market cap | 2.114B |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3000 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.20 |
Simply Wall St.Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future
We feel now is a pretty good time to analyse Geron Corporation's ( NASDAQ:GERN ) business as it appears the company may...
Business WireGeron to Participate at Upcoming Investor Conferences in April
FOSTER CITY, Calif., April 03, 2024--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to present at the following virtual investor conferences:
ZacksBiotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
Geron Corporation (GERN) and Crinetics Pharmaceuticals (CRNX) gain on positive regulatory and study updates.
© 2024 Yahoo. All rights reserved.